TY - THES A1 - Hellinger, Michaela T1 - Untersuchung der Lebensqualität nach operativer Behandlung von Oropharynx- und Mundhöhlenkarzinomen T1 - Examination of the Quality of Life after operative Treatment of Oropharynx and Oral Cavity Cancer N2 - Die Ergebnisse dieser Studie geben einen Überblick über den Gesundheitszustand und die Lebensqualität der Patienten nach der operativen Therapie eines Oropharynx- oder Mundhöhlenkarzinomes. Die Lebensqualität des Einzelnen ist ein komplexes Konstrukt und von den individuellen Werten und Einschätzungen des Patienten abhängig. Die Gesamtwerte des Patientenkollektives können nur gemeinsame Tendenzen beschreiben. Insgesamt wurde die Lebensqualität als wenig beeinträchtigt eingeschätzt. Die Betrachtung der Einzelwerte ergaben jedoch für 50% der Befragten eine mäßige Reduktion der Lebensqualität und des Gesundheitsstatus. Die epidemiologischen und ätiologischen Faktoren konnten bestätigt werden. Die Patienten reagierten nach der Operation in Bezug auf die Risikofaktoren einsichtig und verneinten den Alkohol- und Zigarettenkonsum oder schränkten ihn stark ein. Die Aufklärung und die Wiederentscheidung für die einzelnen Therapiearten wurde von den Patienten positiv beurteilt. Hier zeigte die Studie ein hohes Maß an Akzeptanz der postoperativ auftretenden somatischen Einschränkungen, wodurch die subjektive Bewertung der Lebensqualität positiv beeinflusst wurde. Zu den stark lebensqualitätsmindernden Symptomen gehörten die Xerostomie und die Dysphagie. Die Speisen mussten stark zerkleinert und verflüssigt werden, damit ein Schlucken möglich war. Die erschwerte Nahrungsaufnahme kann die Anwendung von oraler Zusatzernährung und den Gebrauch einer Ernährungssonde erfordern, um einen ausreichenden Ernährungszustand zu gewährleisten. Der Gebrauch einer Ernährungssonde wirkte eher lebensqualitätsmindernd, als die regelmäßige orale Einnahme von kommerziellen flüssigen Formulardiäten. Auch die Einschränkung der Bewegungsfreiheit des Kopfes und des Armes als Folge der Neck-dissection gehörte mit zu den stärker mindernden Faktoren. Der Vergleich höherer zu niedrigerer subjektiv empfundener Lebensqualität und Gesundheitsstatus läßt die Annahme zu, dass Patienten, die durch allgemeine Schwäche und Schmerzen, sowie einer dauerhaften Schmerzmitteleinnahme täglich an ihre Erkrankung erinnert werden, ihren Gesundheitsstatus und ihre Lebensqualität als stärker vermindert einschätzen. N2 - The results of this study give a summary of the health condition and the quality of life of the patients after the operative therapy of oropharynx or oral cavity cancer. The quality of life of the single is a complex construct and addicted to the individual results and opinions of the patient. The total values of the patient collective can describe only common trends. The quality of life altogether was assessed as impaired little. However for 50% questioned the consideration of the single results yielded a moderate diminution of the quality of life and the health status. The epidemiological and etiologic factors could be confirmed. The patients after the operation reacted with respect to the risk factors reasonably and denied the alcohol and cigarette consumption or limited him strongly. The clearing up and the re-decision for the single therapy ways judged positively by the patients. The study showed a high degree of acceptance of the somatic reductions appearing post operatively, through what the subjective assessment of the quality of life was influenced positively here. The xerostomia and the dysphagia were part of the symptoms quality of life diminishing strongly. The foods had strongly to be reduced to small pieces and liquefied so that a swallowing was possible. The aggravated eating can require the application of oral additional diet and the use of a diet probe to ensure a sufficient diet condition. The use of a diet probe seemed quality of life diminishing sooner as the regular oral taking of commercial liquid food. The reduction of the movement liberty of the head and the arm as consequence of the neck-dissection was part of the factors diminishing more strongly. The comparison of higher too lower subjectively felt quality of life and health status allows the assumption that patients who are reminded by general weakness and pains as well as durable pain-killer taking of her illness daily assess her health status and her quality of life as reduced more strongly. KW - Lebensqualität Fragebogen KW - Kopf- und Halskrebs KW - Oropharynx KW - Mundhöhlenkarzinom KW - Xerostomie KW - quality of life questionnaire KW - head and neck cancer KW - oropharynx KW - oral cavity cancer KW - xerostomia Y1 - 2003 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-6543 ER - TY - JOUR A1 - Linz, Christian A1 - Brands, Roman C. A1 - Kertels, Olivia A1 - Dierks, Alexander A1 - Brumberg, Joachim A1 - Gerhard-Hartmann, Elena A1 - Hartmann, Stefan A1 - Schirbel, Andreas A1 - Serfling, Sebastian A1 - Zhi, Yingjun A1 - Buck, Andreas K. A1 - Kübler, Alexander A1 - Hohm, Julian A1 - Lapa, Constantin A1 - Kircher, Malte T1 - Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [\(^{18}\)F]FDG PET/CT and MRI JF - European Journal of Nuclear Medicine and Molecular Imaging N2 - Purpose While [\(^{18}\)F]-fluorodeoxyglucose ([\(^{18}\)F]FDG) is the standard for positron emission tomography/computed tomography (PET/CT) imaging of oral squamous cell carcinoma (OSCC), diagnostic specificity is hampered by uptake in inflammatory cells such as neutrophils or macrophages. Recently, molecular imaging probes targeting fibroblast activation protein α (FAP), which is overexpressed in a variety of cancer-associated fibroblasts, have become available and might constitute a feasible alternative to FDG PET/CT. Methods Ten consecutive, treatment-naïve patients (8 males, 2 females; mean age, 62 ± 9 years) with biopsy-proven OSCC underwent both whole-body [\(^{18}\)F]FDG and [\(^{68}\)Ga]FAPI-04 (FAP-directed) PET/CT for primary staging prior to tumor resection and cervical lymph node dissection. Detection of the primary tumor, as well as the presence and number of lymph node and distant metastases was analysed. Intensity of tracer accumulation was assessed by means of maximum (SUV\(_{max}\)) and peak (SUV\(_{peak}\) standardized uptake values. Histological work-up including immunohistochemical staining for FAP served as standard of reference. Results [\(^{18}\)F]FDG and FAP-directed PET/CT detected all primary tumors with a SUVmax of 25.5 ± 13.2 (FDG) and 20.5 ± 6.4 (FAP-directed) and a SUVpeak of 16.1 ± 10.3 ([\(^{18}\)F]FDG) and 13.8 ± 3.9 (FAP-directed), respectively. Regarding cervical lymph node metastases, FAP-directed PET/CT demonstrated comparable sensitivity (81.3% vs. 87.5%; P = 0.32) and specificity (93.3% vs. 81.3%; P = 0.16) to [\(^{18}\)F]FDG PET/CT. FAP expression on the cell surface of cancer-associated fibroblasts in both primary lesions as well as lymph nodes metastases was confirmed in all samples. Conclusion FAP-directed PET/CT in OSCC seems feasible. Future research to investigate its potential to improve patient staging is highly warranted. KW - molecular imaging KW - fibroblast activation protein KW - head and neck cancer KW - PET Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-307246 SN - 1619-7070 SN - 1619-7089 VL - 48 IS - 12 ER - TY - JOUR A1 - Polat, Bülent A1 - Kaiser, Philipp A1 - Wohlleben, Gisela A1 - Gehrke, Thomas A1 - Scherzad, Agmal A1 - Scheich, Matthias A1 - Malzahn, Uwe A1 - Fischer, Thomas A1 - Vordermark, Dirk A1 - Flentje, Michael T1 - Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer JF - BMC Cancer N2 - Background: In head and neck cancer little is known about the kinetics of osteopontin (OPN) expression after tumor resection. In this study we evaluated the time course of OPN plasma levels before and after surgery. Methods: Between 2011 and 2013 41 consecutive head and neck cancer patients were enrolled in a prospective study (group A). At different time points plasma samples were collected: T0) before, T1) 1 day, T2) 1 week and T3) 4 weeks after surgery. Osteopontin and TGFβ1 plasma concentrations were measured with a commercial ELISA system. Data were compared to 131 head and neck cancer patients treated with primary (n = 42) or postoperative radiotherapy (n = 89; group B1 and B2). Results: A significant OPN increase was seen as early as 1 day after surgery (T0 to T1, p < 0.01). OPN levels decreased to base line 3-4 weeks after surgery. OPN values were correlated with postoperative TGFβ1 expression suggesting a relation to wound healing. Survival analysis showed a significant benefit for patients with lower OPN levels both in the primary and postoperative radiotherapy group (B1: 33 vs 11.5 months, p = 0.017, B2: median not reached vs 33.4, p = 0.031). TGFβ1 was also of prognostic significance in group B1 (33.0 vs 10.7 months, p = 0.003). Conclusions: Patients with head and neck cancer showed an increase in osteopontin plasma levels directly after surgery. Four weeks later OPN concentration decreased to pre-surgery levels. This long lasting increase was presumably associated to wound healing. Both pretherapeutic osteopontin and TGFβ1 had prognostic impact. KW - perioperative changes KW - osteopontin KW - TGFβ1 KW - head and neck cancer KW - survival Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-157529 VL - 17 IS - 6 ER - TY - JOUR A1 - Wohlleben, Gisela A1 - Scherzad, Agmal A1 - Güttler, Antje A1 - Vordermark, Dirk A1 - Kuger, Sebastian A1 - Flentje, Michael A1 - Polat, Buelent T1 - Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines JF - Radiation Oncology N2 - Background Tumor hypoxia is a known risk factor for reduced response to radiotherapy. The evaluation of noninvasive methods for the detection of hypoxia is therefore of interest. Osteopontin (OPN) has been discussed as an endogenous hypoxia biomarker. It is overexpressed in many cancers and is involved in tumor progression and metastasis. Methods To examine the influence of hypoxia and irradiation on osteopontin expression we used different cell lines (head and neck cancer (Cal27 and FaDu) and glioblastoma multiforme (U251 and U87)). Cells were treated with hypoxia for 24 h and were then irradiated with doses of 2 and 8 Gy. Osteopontin expression was analyzed on mRNA level by quantitative real-time RT-PCR (qPCR) and on protein level by western blot. Cell culture supernatants were evaluated for secreted OPN by ELISA. Results Hypoxia caused an increase in osteopontin protein expression in all cell lines. In Cal27 a corresponding increase in OPN mRNA expression was observed. In contrast the other cell lines showed a reduced mRNA expression under hypoxic conditions. After irradiation OPN mRNA expression raised slightly in FaDu and U87 cells while it was reduced in U251 and stable in Cal27 cells under normoxia. The combined treatment (hypoxia and irradiation) led to a slight increase of OPN mRNA after 2 Gy in U251 (24 h) and in U87 (24 and 48 h) cell lines falling back to base line after 8 Gy. This effect was not seen in Cal27 or in FaDu cells. Secreted OPN was detected only in the two glioblastoma cell lines with reduced protein levels under hypoxic conditions. Again the combined treatment resulted in a minor increase in OPN secretion 48 hours after irradiation with 8 Gy. Conclusion Osteopontin expression is strongly modulated by hypoxia and only to a minor extent by irradiation. Intracellular OPN homeostasis seems to vary considerably between cell lines. This may explain the partly conflicting results concerning response prediction and prognosis in the clinical setting. KW - glioblastoma multiforme KW - head and neck cancer KW - irridation KW - hypoxia KW - osteopontin Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-125746 VL - 10 IS - 167 ER -